BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI) (“Cigna”) today announced the enterprise leadership team for the combined Cigna and Express Scripts Holding Company (NASDAQ: ESRX) (“Express Scripts”) business following the close of their proposed transaction.
"This team is uniquely qualified to drive the improvements in affordability, choice and quality for our customers and clients, as well as the sustained attractive return for our shareholders, that this combination will deliver,” said David M. Cordani, President and Chief Executive Officer of Cigna. “I look forward to working with these highly-accomplished and experienced leaders. Together, we will achieve significant growth and accelerate the pace of change in health care in ways that continue to improve lives.”
Upon closing, the combined company will offer multiple growth platforms:
- A commercial business, including employer-sponsored medical coverage,
- A government business, including Medicare offerings to seniors,
- An international business, including global supplemental benefits and
- A health services business, including Express Scripts.
As previously announced, David Cordani will serve as President and Chief Executive Officer of the combined company. Express Scripts President and Chief Executive Officer Tim Wentworth will head the health services business as President, Express Scripts and Cigna Services.
Additionally, the following executives will be members of the combined company’s enterprise leadership team, reporting to David Cordani:
- Lisa Bacus, Chief Marketing Officer
- Mark Boxer, Chief Information Officer
- Brian Evanko, President, U.S. Government Business
- Nicole Jones, General Counsel
- Matthew Manders, President, Strategy & Solutions
- Dr. Steven Miller, Chief Clinical Officer
- John Murabito, Chief Human Resources Officer
- Eric Palmer, Chief Financial Officer
- Jason Sadler, President, International Markets
- Michael Triplett, President, U.S. Commercial Business
Cigna and Express Scripts are working diligently through remaining regulatory reviews and the integration planning process. Until the close of the transaction, Cigna and Express Scripts continue to operate as two independent companies under their current leadership structures. The companies anticipate that the transaction will close by year-end 2018, subject to the satisfaction of all closing conditions.
Additional information is available at www.advancinghealthcare.com.
About Cigna
Cigna Corporation (NYSE: CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Life Insurance Company of North America, Cigna Life Insurance Company of New York, or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance. Cigna maintains sales capability in over 30 countries and jurisdictions, and has more than 95 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com. For more information about Cigna's proposed acquisition of Express Scripts, please visit www.advancinghealthcare.com.
